US2019307831A1PendingUtilityA1

Materials and methods for treatment of inflammation

62
Assignee: CYTOGEL PHARMA LLCPriority: May 21, 2010Filed: Jun 24, 2019Published: Oct 10, 2019
Est. expiryMay 21, 2030(~3.9 yrs left)· nominal 20-yr term from priority
A61P 37/08A61P 37/06A61P 37/00A61P 5/00A61P 7/10A61P 43/00A61P 31/04A61P 29/00A61P 25/02A61P 25/04A61P 25/06A61P 11/06A61P 19/00A61P 17/18A61P 25/00A61P 1/00A61P 19/02A61P 1/04A61P 17/02A61P 19/08A61P 17/06A61P 17/00A61K 38/04A61P 25/30A61P 25/36A61K 38/07
62
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The subject invention pertains to peptides and salts thereof that are useful as anti-inflammatory agents and to compositions containing such peptides and salts as active ingredients. Specifically exemplified herein are endomorphin-1 peptide (EM-1), analogs and salts thereof, and uses for modulation of calcitonin gene-related peptide (CGRP) production and/or substance P (SP) and for treatment of inflammation, particularly neurogenic inflammation.

Claims

exact text as granted — not AI-modified
We claim: 
     
         1 . A composition comprising SEQ ID NO: 13 and hydroxypropyl-3 cyclodextrin (HPCD) in water. 
     
     
         2 . The composition, according to  claim 1 , wherein the concentration of HPCD is about 20% and the water is sterile distilled water. 
     
     
         3 . The composition, according to  claim 1 , wherein the composition is clear. 
     
     
         4 . The composition, according to  claim 1 , which is a solution. 
     
     
         5 . The composition, according to  claim 1 , further comprising acetate ions. 
     
     
         6 . A method for treating a human subject to reduce inflammation and/or modulate an immune response, wherein said method comprises administering to a human subject in need of such treatment, an effective amount of the composition of  claim 1 . 
     
     
         7 . The method, according to  claim 6 , further comprising administering an anti-inflammatory agent selected from the group consisting of a steroidal compound, hydrocortisone, a non-steroidal anti-inflammatory compound, acetylsalicylic acid (aspirin), ibuprofen, acetaminophen, and indomethacin.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.